Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan

Authors

  • Thomas C. Yau Division of Haematology/Oncology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong
  • Kin W. Chu Suite 331, Central Building, 1–3 Pedder Street, Central, Hong Kong
  • Mo Y. Mok Division of Rheumatology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong
  • Raymond H. Liang Division of Haematology/Oncology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong
  • Richard J. Epstein Division of Haematology/Oncology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong

DOI:

https://doi.org/10.1080/02841860500218652

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2005-01-01

How to Cite

Yau, T. C., Chu, K. W., Mok, M. Y., Liang, R. H., & Epstein, R. J. (2005). Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan. Acta Oncologica, 44(7), 771–772. https://doi.org/10.1080/02841860500218652

Issue

Vol. 44 No. 7 (2005): Acta Oncologica

Section

Articles